A Practical Approach to Early-Phase CMC
February 20, 2026
Integrated, risk-based chemistry, manufacturing and controls strategies support early-phase development, writes Richard Chubb
6 min read
False
Advertisement
Future of Pharma
Building Better Oral Suspensions for Pediatric & Real-World Use
February 18, 2026
Greg Thomas, Kiel Laboratories’ Vice President of R&D, discusses oral suspensions, excipients, and patient-centered formulation
4 min read
Oral BTK Inhibitor Shows Disability Benefit in Progressive Multiple Sclerosis Trial
February 17, 2026
Phase 3 results show fenebrutinib matched OCREVUS on disability progression in PPMS
2 min read
New Novartis Biomedical Research Facility Planned for San Diego
February 16, 2026
Part of a broader multibillion-dollar effort to expand R&D and manufacturing in the US
1 min read
Why AI, Cloud & Sustainability Strategies May Collide
By Martyn Williams
February 16, 2026
UK pharma’s digital ambition is starting to work against it, writes Martyn Williams of COPA-DATA UK
3 min read
Scaling Smarter: How Continuous Manufacturing Is Reshaping Drug Development
February 13, 2026
Twin-screw extrusion’s role in enabling precise, scalable pharmaceutical manufacturing
7 min read
New Collaboration to Automate Cell Therapy Manufacturing with Robotics
February 12, 2026
Focus on scaling cell therapy manufacturing using GMP-ready end-to-end robotic biomanufacturing technology
1 min read
Solving the Problem of Insolubility: Part I
February 11, 2026
As drug discovery unlocks harder, more powerful molecules, solubility has become the bottleneck. The first of a three-part series discusses the roots of the problem
5 min read
Electronic Lab Notebooks Are Failing Scientists and Inflating R&D Costs
February 10, 2026
New survey finds outdated lab software is driving experiment duplication, workflow bottlenecks, and risky shadow AI use
2 min read
Enhancing Sterile Drug Quality with AI-Driven Inspection
By Christy Eatmon
February 9, 2026
Bringing speed, consistency, and insight to sterile drug inspection
3 min read
